Ipratropium Bromide Solution
Product Images NDC 76204-100

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 76204-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rpsc0269 Rdp 0.02 25 Ct Brick Carton

The label depicts packaging for Ipratropium Bromide Inhalation Solution, 0.02%, with a strength of 0.5 mg per 2.5 mL. It is for oral inhalation only and contains 25 unit-dose vials. The labeler is Ritedose Pharmaceuticals, LLC, with the NDC 76204-100-25. The label features blue and green bands and includes prescription-only (Rx) designation.*

FDA Label Image

Rpsc0270 Rdp 0.02 30 Ct Brick Carton

Packaging label for Ipratropium Bromide Inhalation Solution 0.02%, 0.5 mg/2.5 mL, by Ritedose Pharmaceuticals, LLC. The label indicates the product is for oral inhalation only and comes as 30 sterile unit-dose vials of 2.5 mL each. The NDC on the label is 76204-100-30, and the label features purple and green color bands.*

FDA Label Image

Rpsc0271 Rdp 0.02 60 Ct Brick Carton

Packaging label for Ipratropium Bromide Inhalation Solution 0.02%, 0.5 mg/2.5 mL, by Ritedose Pharmaceuticals, LLC. The label includes the NDC 76204-100-60 and indicates the product is for oral inhalation only. The design features purple and green stripes with text emphasizing the strength and usage directions. Multiple barcodes and manufacturer information are also present.*

FDA Label Image

Rpsc0300 Rdp 0.02 30 Ct Singles Carton

Packaging label for Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL by Ritedose Pharmaceuticals, LLC. The label indicates it is for oral inhalation only and contains 30 sterile unit-dose vials, each with 2.5 mL of solution. The NDC 76204-100-01 and barcode are visible on the package.*

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical structure diagram of Ipratropium Bromide, showing atomic bonds and molecular groups including a quaternary ammonium ion and a benzene ring, with associated bromide and water molecules indicated.*

FDA Label Image

Figure 1 (Ipratropium 02)

Illustration showing a person holding an inverted vial bottle, preparing to use the solution. The vial is grasped near the top, with the fingers positioned for opening or administering the respiratory inhalation solution, Ipratropium Bromide 0.5 mg/2.5 mL.*

FDA Label Image

Figure 2 (Ipratropium 03)

An instructional illustration showing a close-up of a device component with arrows indicating directions for adjustment or movement. Labeled as Figure 2, the diagram appears to demonstrate a step in the usage or assembly process of a respiratory inhalation device related to Ipratropium Bromide solution.*

FDA Label Image

Figure 3 (Ipratropium 04)

An instructional illustration labeled Figure 3 showing a person using an inhalation device. The image depicts the person placing the mouthpiece of the device into their mouth, demonstrating the correct way to inhale a solution inhaler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.